Advertisement
Singapore markets close in 1 hour 29 minutes
  • Straits Times Index

    3,289.88
    +23.93 (+0.73%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,962.76
    +424.95 (+2.29%)
     
  • FTSE 100

    8,422.11
    +40.76 (+0.49%)
     
  • Bitcoin USD

    63,234.54
    +1,739.58 (+2.83%)
     
  • CMC Crypto 200

    1,354.87
    -3.14 (-0.23%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • Dow

    39,387.76
    +331.36 (+0.85%)
     
  • Nasdaq

    16,346.26
    +43.46 (+0.27%)
     
  • Gold

    2,374.20
    +33.90 (+1.45%)
     
  • Crude Oil

    79.77
    +0.51 (+0.64%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • FTSE Bursa Malaysia

    1,601.39
    +0.17 (+0.01%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

IHH Healthcare says no wrongdoing found in Fortis investment

In its statement, IHH expressed its commitment to “stand firm” on Fortis’ side to “continue this growth journey”.

IHH Healthcare, on Sept 26, released a statement to reaffirm its commitment to its patients in India, to Fortis as well as investors in the group.

The statement was made after the group was “aware” that there was “keen interest” regarding the latest judgement made by the Indian Supreme Court on “various legal proceedings undertaken by Daiichi Sankyo Company Limited in relation to certain other parties, into which Fortis Healthcare Limited (Fortis) has been drawn.”

The statement also referred to an article dated Sept 23 by The Edge Markets, which noted the slip in IHH’s share price on the Malaysian Bursa to the lowest in 13 months. The same was true for IHH’s SGX-listed shares, which came in at a 52-week low as at the close of Sept 23. The decline in share price came after the Indian Supreme Court’s decision to not lift the stay on IHH’s open offer for shares in Fortis.

ADVERTISEMENT

Read the rest of the story here.

In its statement, IHH Healthcare noted that the court did not find or indicate any wrongdoing by the group in terms of their investment in Fortis.

Furthermore, the judgement from the Indian Supreme Court “supports [the group’s] belief that [its] investment into Fortis was undertaken in a fair and transparent manner”.

“We remain steadfast in our ability and commitment to execute our business plans to grow our operations and serve the healthcare needs of our patients in India with care and excellence while protecting the interests of our stakeholders,” it adds.

In addition, IHH expressed its commitment to “stand firm” on Fortis’ side to “continue this growth journey”. “Over the last quarter and through the pandemic, Fortis has anchored its claim as one of the leading healthcare platforms in India,” the group says.

Besides, the special leave petition (SLP), the original contempt petition and the suo moto contempt petition were made with a direction to the high court to analyse the transactions entered into between Fortis and RHT Health Trust through the “appropriate processes”.

As at Sept 26, IHH remains Fortis’ largest shareholder with a 31.1% stake.

Shares in IHH closed 4 cents higher or 2.24% up at $1.83 on Sept 26.

See Also: